Friday, 19 Jul 2019

You are here

The RheumNow Week in Review - 12 January 2018

Dr. Jack Cush reviews a dozen highlights from the past week on RheumNow.com.

  1. Study of THR in Hip arthritis patients shows that Surgeons who do "overlapping surgeries" (supervises 2+ operations simultaneously) have a 90% in surgical complications in 1st yr. https://t.co/E8pQY2S1jg 
  2. Metanalysis of the RA cost of care (12 papers, only1/3 good) shows Total direct medical costs to be ~ $12,509 for all RA pts; $36,053 for bDMARD users; RA-specific costs were $3,723 all RA patients and $20K for bDMARD users https://t.co/JYzgrUgnfF
  3. DMARD Tip: Leflunomide has a drug 1/2 life of nearly 20 days. Once pt improved w/ 20mg/d (~6-12 wks) I switch dosing to once weekly, often less total mg (eg, LEF 4-6 tab q friday (80-120mg/wk). Monitoring and risks are same. https://t.co/dP7EooQEKz
  4. 8,534 FMF Israeli patients were found to have a lower risk of Cancer (SIR 0.66;(95% CI 0.55–0.77). The question: is: inflammation-related Cancer risk different with disorders of adaptive vs innate immunity? https://t.co/s5iFYhmvhF
  5. Krystexxa annual sales expected to increase from $400 million to $750 million. Horizon reports the number of gout patients treated increased from 50,000 to 100,000. https://t.co/sPTf8UueVc
  6. Swedish study of 331,941 construction workers (31 years F/U): 1,623 had lumbar spinal stenosis surgery, with rates highest in those who were heavy smokers https://t.co/XNbLYdARjc
  7. Gabapentinoid use steadily rose from 1.2% of adults in 2002 to 3.9% in 2015 https://t.co/seC0thDIX9
  8. Study of ~300k Canadian pregnancies (1998-2015) finds 51 LEF patients with 1st Trimester exposures to Arava & 21 patients with 2nd/3rd Tri exposure; Find no incr risk of spont Abortion (11), Malformations (5), prematurity (7) or LBW (8) https://t.co/jsVXdvQGEM
  9. B Cell Changes Predict Autoimmunity with Checkpoint Inhibitors   
  10. 40% of Arthritis Patients Fail to Receive Exercise Guidance  
  11. Increasing Adverse Events Seen with Higher Disease Activity in Early RA
  12. Calcium and Vitamin D Supplements Do Not Reduce Hip Fractures 

 

Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

RheumNow Podcast – Don’t Take My Advice (7.19.19)

Dr. Jack Cush reports the news and new journal articles from the past week on RheumNow.com.

RheumNow Podcast – Boiling Hot MAS (7.12.19)

Dr. Jack Cush reviews this week's news and journal reports featured on RheumNow.com. PsA v. non-PsA pregnancies, Still's disease, lupus, nutritional supplements and dietary interventions, use of cannabis, tanezumab in OA, CBD oils and more.

Be ‘on point’: Guidelines for rheumatic complications of immunotherapy

Editor's note: July 1 - 5, RheumNow is running the best of the EULAR 2019 meeting. At EULAR 2019, Madrid, several recommendations including RA, SLE, and Sjogren’s syndrome have been developed. Agreement for principles with respect to the treatment of immune mediated adverse events from cancer immunotherapy are lacking.

RheumNow Podcast – EULAR 2019 Streamin' - (6.14.19)

Editor's note: July 1 - 5, RheumNow is running the best of the EULAR 2019 meeting. Dr. Jack Cush reports from Madrid on several novel presentations from EULAR 2019, including low-dose steroids in hand OA, ABA vs. ADA in double positive RA patients, psoriasis predictors of PsA, tildrakizumab and more.

EULAR 2019 – Day 3 Report

Editor's note: July 1 - 5, RheumNow is running the best of the EULAR 2019 meeting. The third day of EULAR 2019 started with novel biologics, the efficacy of secukinumab in axial psoriatic arthritis, neurologic events with TNF inhibitors from the DANBIO database (OP0261), and neuropathy in SLE (OP0252), but above all this was a big poster day. Here are selected highlights from day 3 EULAR in Madrid.